Cwm LLC Takes $95,000 Position in Haleon plc (NYSE:HLN)

Cwm LLC acquired a new stake in shares of Haleon plc (NYSE:HLN – Get Rating) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 15,670 shares of the company’s stock, valued at approximately $95,000.

Several other institutional investors also recently bought and sold shares of the company. Fractal Investments LLC acquired a new stake in Haleon in the third quarter valued at approximately $183,000. Blue Barn Wealth LLC acquired a new stake in Haleon in the third quarter valued at approximately $95,000. Canal Insurance CO acquired a new stake in Haleon in the third quarter valued at approximately $609,000. Ballentine Partners LLC acquired a new stake in Haleon in the third quarter valued at approximately $106,000. Finally, Truist Financial Corp acquired a new stake in Haleon in the third quarter valued at approximately $1,052,000. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Price Performance

Shares of Haleon stock opened at $8.15 on Wednesday. The business’s fifty day simple moving average is $7.44. Haleon plc has a 1 year low of $5.59 and a 1 year high of $8.50.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on HLN. Morgan Stanley upgraded shares of Haleon from an “equal weight” rating to an “overweight” rating in a research note on Friday, January 6th. Argus started coverage on shares of Haleon in a report on Wednesday, September 28th. They issued a “hold” rating for the company. Finally, Barclays raised shares of Haleon from an “equal weight” rating to an “overweight” rating in a report on Wednesday, December 7th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $298.00.

Haleon Company Profile

(Get Rating)

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.